{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:50Z","timestamp":1794014870746,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CE17-0007-01"],"award-info":[{"award-number":["ANR-16-CE17-0007-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IBHU-004"],"award-info":[{"award-number":["ANR-10-IBHU-004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["PME20180639518"],"award-info":[{"award-number":["PME20180639518"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Etablissement Fran\u00e7ais du Sang Fondation du rein","id":[{"id":"https:\/\/ror.org\/049fhwy88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current doctrine is that microvascular inflammation (MVI) triggered by a transplant -recipient antibody response against alloantigens (antibody-mediated rejection) is the main cause of graft failure. Here, we show that histological lesions are not mediated by antibodies in approximately half the participants in a cohort of 129 renal recipients with MVI on graft biopsy. Genetic analysis of these patients shows a higher prevalence of mismatches between donor HLA I and recipient inhibitory killer cell immunoglobulin-like receptors (KIRs). Human in vitro models and transplantation of \u03b22-microglobulin-deficient hearts into wild-type mice demonstrates that the inability of graft endothelial cells to provide HLA I-mediated inhibitory signals to recipient circulating NK cells triggers their activation, which in turn promotes endothelial damage. Missing self-induced NK cell activation is mTORC1-dependent and the mTOR inhibitor rapamycin can prevent the development of this type of chronic vascular rejection.<\/jats:p>","DOI":"10.1038\/s41467-019-13113-5","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:02:49Z","timestamp":1574661769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":214,"title":["Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants"],"prefix":"10.1038","volume":"10","author":[{"given":"Alice","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1282-976X","authenticated-orcid":false,"given":"Chien-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Mar\u00e7ais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Rabeyrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Racap\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Duong-Van-Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bruneval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Dussurgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vannary","family":"Meas-Yedid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Olivo-Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e9na","family":"Paidassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Guillemain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Taupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Callemeyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5870-4615","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Charreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Defrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"13113_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/tri.13059","volume":"31","author":"R Reindl-Schwaighofer","year":"2018","unstructured":"Reindl-Schwaighofer, R., Heinzel, A., Signorini, L., Thaunat, O. & Oberbauer, R. Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses. Transplant. Int. 31, 239\u2013250 (2018).","journal-title":"Transplant. Int."},{"key":"13113_CR2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","volume":"2","author":"RY Calne","year":"1978","unstructured":"Calne, R. Y. et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2, 1323\u20131327 (1978).","journal-title":"Lancet"},{"key":"13113_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","volume":"11","author":"KE Lamb","year":"2011","unstructured":"Lamb, K. E., Lodhi, S. & Meier-Kriesche, H.-U. Long-term renal allograft survival in the United States: a critical reappraisal. Am. J. Transplant. 11, 450\u2013462 (2011).","journal-title":"Am. J. Transplant."},{"key":"13113_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","volume":"17","author":"PI Terasaki","year":"2005","unstructured":"Terasaki, P. I. & Cai, J. Humoral theory of transplantation: further evidence. Curr. Opin. Immunol. 17, 541\u2013545 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"13113_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","volume":"4","author":"PI Terasaki","year":"2004","unstructured":"Terasaki, P. I. & Ozawa, M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am. J. Transplant. 4, 438\u2013443 (2004).","journal-title":"Am. J. Transplant."},{"key":"13113_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.12703\/P7-51","volume":"7","author":"E Pouliquen","year":"2015","unstructured":"Pouliquen, E. et al. Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000prime Rep. 7, 51 (2015).","journal-title":"F1000prime Rep."},{"key":"13113_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s, J. et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transplant. 12, 388\u2013399 (2012).","journal-title":"Am. J. Transplant."},{"key":"13113_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","volume":"12","author":"C Wiebe","year":"2012","unstructured":"Wiebe, C. et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am. J. Transplant. 12, 1157\u20131167 (2012).","journal-title":"Am. J. Transplant."},{"key":"13113_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ajt.13529","volume":"16","author":"A Loupy","year":"2016","unstructured":"Loupy, A. et al. Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection. Am. J. Transplant. 16, 111\u2013120 (2016).","journal-title":"Am. J. Transplant."},{"key":"13113_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/ajt.13589","volume":"16","author":"A Roux","year":"2016","unstructured":"Roux, A. et al. Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics. Am. J. Transplant. 16, 1216\u20131228 (2016).","journal-title":"Am. J. Transplant."},{"key":"13113_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","volume":"11","author":"D Cantarovich","year":"2011","unstructured":"Cantarovich, D. et al. Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome. Am. J. Transplant. 11, 2737\u20132746 (2011).","journal-title":"Am. J. Transplant."},{"key":"13113_CR12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MOT.0000000000000242","volume":"20","author":"O Thaunat","year":"2015","unstructured":"Thaunat, O. et al. Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation? Curr. Opin. Organ Transplant. 20, 596\u2013601 (2015).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"13113_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1172\/JCI93542","volume":"128","author":"C-C Chen","year":"2018","unstructured":"Chen, C.-C. et al. Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection. J. Clin. Invest. 128, 219\u2013232 (2018).","journal-title":"J. Clin. Invest."},{"key":"13113_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","volume":"369","author":"A Loupy","year":"2013","unstructured":"Loupy, A. et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N. Engl. J. Med. 369, 1215\u20131226 (2013).","journal-title":"N. Engl. J. Med."},{"key":"13113_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1681\/ASN.2013101144","volume":"26","author":"A Sicard","year":"2015","unstructured":"Sicard, A. et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J. Am. Soc. Nephrol. 26, 457\u2013467 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"13113_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2014040326","volume":"27","author":"G Guidicelli","year":"2016","unstructured":"Guidicelli, G. et al. Non-complement\u2013binding de novo donor-specific anti-HLA antibodies and kidney allograft survival. J. Am. Soc. Nephrol. 27, 615\u2013625 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"13113_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1600-6143.2009.02958.x","volume":"10","author":"T Hirohashi","year":"2010","unstructured":"Hirohashi, T. et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am. J. Transplant. 10, 510\u2013517 (2010).","journal-title":"Am. J. Transplant."},{"key":"13113_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.humimm.2012.07.011","volume":"73","author":"GA Fishbein","year":"2012","unstructured":"Fishbein, G. A. & Fishbein, M. C. Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft. Hum. Immunol. 73, 1213\u20131217 (2012).","journal-title":"Hum. Immunol."},{"key":"13113_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2015.276","volume":"89","author":"A Gupta","year":"2016","unstructured":"Gupta, A. et al. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies. Kidney Int. 89, 217\u2013225 (2016).","journal-title":"Kidney Int."},{"key":"13113_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas, M. et al. The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am. J. Transplant. 18, 293\u2013307 (2018).","journal-title":"Am. J. Transplant."},{"key":"13113_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","volume":"90","author":"D Dragun","year":"2016","unstructured":"Dragun, D., Catar, R. & Philippe, A. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity. Kidney Int. 90, 280\u2013288 (2016).","journal-title":"Kidney Int."},{"key":"13113_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2013121277","volume":"26","author":"AM Jackson","year":"2015","unstructured":"Jackson, A. M. et al. Endothelial cell antibodies associated with novel targets and increased rejection. J. Am. Soc. Nephrol. 26, 1161\u20131171 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"13113_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MOT.0000000000000329","volume":"21","author":"A Sicard","year":"2016","unstructured":"Sicard, A., Chen, C.-C., Morelon, E. & Thaunat, O. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection. Curr. Opin. Organ Transplant. 21, 368\u2013374 (2016).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"13113_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ki.2011.317","volume":"81","author":"O Thaunat","year":"2012","unstructured":"Thaunat, O. et al. A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection. Kidney Int. 81, 207\u2013219 (2012).","journal-title":"Kidney Int."},{"key":"13113_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0002-9440(10)62557-6","volume":"160","author":"SA Joosten","year":"2002","unstructured":"Joosten, S. A. et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am. J. Pathol. 160, 1301\u20131310 (2002).","journal-title":"Am. J. Pathol."},{"key":"13113_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun, D. et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 352, 558\u2013569 (2005).","journal-title":"N. Engl. J. Med."},{"key":"13113_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa067160","volume":"357","author":"Y Zou","year":"2007","unstructured":"Zou, Y., Stastny, P., S\u00fcsal, C., D\u00f6hler, B. & Opelz, G. Antibodies against MICA antigens and kidney-transplant rejection. N. Engl. J. Med. 357, 1293\u20131300 (2007).","journal-title":"N. Engl. J. Med."},{"key":"13113_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1034\/j.1600-6143.2003.00021.x","volume":"3","author":"S Le Bas-Bernardet","year":"2003","unstructured":"Le Bas-Bernardet, S. et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am. J. Transplant. 3, 167\u2013177 (2003).","journal-title":"Am. J. Transplant."},{"key":"13113_CR29","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/j.1600-6143.2008.02303.x","volume":"8","author":"RN Smith","year":"2008","unstructured":"Smith, R. N. et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am. J. Transplant. 8, 1662\u20131672 (2008).","journal-title":"Am. J. Transplant."},{"key":"13113_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.kint.2017.01.011","volume":"92","author":"A Sicard","year":"2017","unstructured":"Sicard, A. et al. Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection. Kidney Int. 92, 214\u2013226 (2017).","journal-title":"Kidney Int."},{"key":"13113_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","volume":"12","author":"T Hirohashi","year":"2012","unstructured":"Hirohashi, T. et al. A novel pathway of chronic allograft rejection mediated by NK Cells and Alloantibody. Am. J. Transplant. 12, 313\u2013321 (2012).","journal-title":"Am. J. Transplant."},{"key":"13113_CR32","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","volume":"10","author":"LG Hidalgo","year":"2010","unstructured":"Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 10, 1812\u20131822 (2010).","journal-title":"Am. J. Transplant."},{"key":"13113_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","volume":"24","author":"A Thielens","year":"2012","unstructured":"Thielens, A., Vivier, E. & Romagn\u00e9, F. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr. Opin. Immunol. 24, 239\u2013245 (2012).","journal-title":"Curr. Opin. Immunol."},{"key":"13113_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","volume":"132","author":"KS Campbell","year":"2011","unstructured":"Campbell, K. S. & Purdy, A. K. Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132, 315\u2013325 (2011).","journal-title":"Immunology"},{"key":"13113_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/icb.2010.78","volume":"89","author":"HJ Pegram","year":"2011","unstructured":"Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K. & Kershaw, M. H. Activating and inhibitory receptors of natural killer cells. Immunol. Cell Biol. 89, 216\u2013224 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"13113_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","volume":"26","author":"M Lucas","year":"2007","unstructured":"Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503\u2013517 (2007).","journal-title":"Immunity"},{"key":"13113_CR37","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1182\/blood-2007-11-122259","volume":"111","author":"S Guia","year":"2008","unstructured":"Guia, S. et al. A role for interleukin-12\/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 111, 5008\u20135016 (2008).","journal-title":"Blood"},{"key":"13113_CR38","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.4049\/jimmunol.181.3.1627","volume":"181","author":"J Chaix","year":"2008","unstructured":"Chaix, J. et al. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181, 1627\u20131631 (2008).","journal-title":"J. Immunol."},{"key":"13113_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fimmu.2012.00339","volume":"3","author":"J Shaw","year":"2012","unstructured":"Shaw, J. & Kollnberger, S. New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease. Front. Immunol. 3, 339 (2012).","journal-title":"Front. Immunol."},{"key":"13113_CR40","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood-2008-03-143727","volume":"112","author":"M Yawata","year":"2008","unstructured":"Yawata, M. et al. MHC class I\u2013specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112, 2369\u20132380 (2008).","journal-title":"Blood"},{"key":"13113_CR41","doi-asserted-by":"crossref","unstructured":"Mar\u00e7ais, A. et al. High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors. eLife 6, https:\/\/doi.org\/10.7554\/eLife.26423 (2017).","DOI":"10.7554\/eLife.26423"},{"key":"13113_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Mar\u00e7ais","year":"2014","unstructured":"Mar\u00e7ais, A. et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749\u2013757 (2014).","journal-title":"Nat. Immunol."},{"key":"13113_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.tp.0000296817.28053.7b","volume":"85","author":"L-E Wai","year":"2008","unstructured":"Wai, L.-E., Fujiki, M., Takeda, S., Martinez, O. M. & Krams, S. M. Rapamycin, but not Cyclosporine or FK506, alters natural killer cell function. Transplantation 85, 145\u2013149 (2008).","journal-title":"Transplantation"},{"key":"13113_CR44","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4049\/jimmunol.1700497","volume":"199","author":"H Jensen","year":"2017","unstructured":"Jensen, H., Potempa, M., Gotthardt, D. & Lanier, L. L. Cutting edge: IL-2-induced expression of the amino acid transporters SLC1A5 and CD98 is a prerequisite for NKG2D-mediated activation of human NK cells. J. Immunol. 199, 1967\u20131972 (2017).","journal-title":"J. Immunol."},{"key":"13113_CR45","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","volume":"9","author":"S Viel","year":"2016","unstructured":"Viel, S. et al. TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci. Signal 9, ra19\u2013ra19 (2016).","journal-title":"Sci. Signal"},{"key":"13113_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li, J., Kim, S. G. & Blenis, J. Rapamycin: one drug, many effects. Cell Metab. 19, 373\u2013379 (2014).","journal-title":"Cell Metab."},{"key":"13113_CR47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/01.tp.0000286097.11173.70","volume":"84","author":"E Kreijveld","year":"2007","unstructured":"Kreijveld, E., van der Meer, A., Tijssen, H. J., Hilbrands, L. B. & Joosten, I. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 84, 1045\u20131051 (2007).","journal-title":"Transplantation"},{"key":"13113_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/ajt.12134","volume":"13","author":"TH Tran","year":"2013","unstructured":"Tran, T. H. et al. No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation. Am. J. Transplant. 13, 1063\u20131068 (2013).","journal-title":"Am. J. Transplant."},{"key":"13113_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood-2007-10-120089","volume":"112","author":"S Laffont","year":"2008","unstructured":"Laffont, S., Seillet, C., Ortaldo, J., Coudert, J. D. & Gu\u00e9ry, J.-C. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 112, 661\u2013671 (2008).","journal-title":"Blood"},{"key":"13113_CR50","first-page":"2845","volume":"118","author":"M Mart\u00ednez-Llordella","year":"2008","unstructured":"Mart\u00ednez-Llordella, M. et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 118, 2845\u20132857 (2008).","journal-title":"J. Clin. Invest."},{"key":"13113_CR51","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1084\/jem.20060603","volume":"203","author":"G Yu","year":"2006","unstructured":"Yu, G., Xu, X., Vu, M. D., Kilpatrick, E. D. & Li, X. C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203, 1851\u20131858 (2006).","journal-title":"J. Exp. Med."},{"key":"13113_CR52","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1681\/ASN.2015070781","volume":"27","author":"O Thaunat","year":"2016","unstructured":"Thaunat, O., Koenig, A., Leibler, C. & Grimbert, P. Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant. J. Am. Soc. Nephrol. 27, 1890\u20131900 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"13113_CR53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/tri.12975","volume":"30","author":"P Grimbert","year":"2017","unstructured":"Grimbert, P. & Thaunat, O. mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now? Transpl. Int. 30, 647\u2013657 (2017).","journal-title":"Transpl. Int."},{"key":"13113_CR54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ctr.12127","volume":"27","author":"N Kamar","year":"2013","unstructured":"Kamar, N. et al. Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen. Clin. Transplant. 27, 455\u2013462 (2013).","journal-title":"Clin. Transplant."},{"key":"13113_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","volume":"12","author":"L Liefeldt","year":"2012","unstructured":"Liefeldt, L. et al. Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation. Am. J. Transplant. 12, 1192\u20131198 (2012).","journal-title":"Am. J. Transplant."},{"key":"13113_CR56","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm.3313","volume":"19","author":"G Canaud","year":"2013","unstructured":"Canaud, G. et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat. Med. 19, 1288\u20131296 (2013).","journal-title":"Nat. Med."},{"key":"13113_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MNH.0000000000000181","volume":"25","author":"Y Yao","year":"2016","unstructured":"Yao, Y. & Inoki, K. The role of mTOR in maintenance of glomerular epithelial cells. Curr. Opin. Nephrol. Hypertens. 25, 28 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"13113_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","volume":"13","author":"B Afzali","year":"2008","unstructured":"Afzali, B., Lombardi, G. & Lechler, R. I. Pathways of major histocompatibility complex allorecognition. Curr. Opin. Organ Transplant. 13, 438\u2013444 (2008).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"13113_CR59","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","volume":"7","author":"J Marino","year":"2016","unstructured":"Marino, J., Paster, J. & Benichou, G. Allorecognition by T lymphocytes and allograft rejection. Front. Immunol. 7, 582 (2016).","journal-title":"Front. Immunol."},{"key":"13113_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fimmu.2018.00275","volume":"9","author":"C-C Chen","year":"2018","unstructured":"Chen, C.-C. et al. CD4+ T cell help is mandatory for naive and memory donor-specific antibody responses: impact of therapeutic immunosuppression. Front. Immunol. 9, 275 (2018).","journal-title":"Front. Immunol."},{"key":"13113_CR61","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/TP.0b013e318188d433","volume":"86","author":"F Qi","year":"2008","unstructured":"Qi, F. et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 86, 1267\u20131274 (2008).","journal-title":"Transplantation"},{"key":"13113_CR62","doi-asserted-by":"publisher","unstructured":"Yazdani, S. et al. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2018.08.027 (2018).","DOI":"10.1016\/j.kint.2018.08.027"},{"key":"13113_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12153","volume":"258","author":"MH Oberbarnscheidt","year":"2014","unstructured":"Oberbarnscheidt, M. H. & Lakkis, F. G. Innate allorecognition. Immunol. Rev. 258, 145\u2013149 (2014).","journal-title":"Immunol. Rev."},{"key":"13113_CR64","first-page":"291","volume":"7","author":"G Cudkowicz","year":"1964","unstructured":"Cudkowicz, G. & Stimpfling, J. H. Deficient growth of C57BL marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus. Immunology 7, 291\u2013306 (1964).","journal-title":"Immunology"},{"key":"13113_CR65","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","volume":"319","author":"K K\u00e4rre","year":"1986","unstructured":"K\u00e4rre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H\u20132-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675\u2013678 (1986).","journal-title":"Nature"},{"key":"13113_CR66","unstructured":"Paul, W.\u00a0Fundamental Immunology (Wolters Kluwer Health, Lippincott Williams & Wilkins, 2013)."},{"key":"13113_CR67","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1126\/science.1133542","volume":"315","author":"K Kim","year":"2007","unstructured":"Kim, K. et al. Histocompatible embryonic stem cells by parthenogenesis. Science 315, 482\u2013486 (2007).","journal-title":"Science"},{"key":"13113_CR68","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.4049\/jimmunol.175.5.3424","volume":"175","author":"S Uehara","year":"2005","unstructured":"Uehara, S. et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J. Immunol. 175, 3424\u20133430 (2005).","journal-title":"J. Immunol."},{"key":"13113_CR69","doi-asserted-by":"publisher","unstructured":"Dai, H. et al. Donor SIRP\u03b1 polymorphism modulates the innate immune response to allogeneic grafts. Sci. Immunol. 2, https:\/\/doi.org\/10.1126\/sciimmunol.aam6202 (2017).","DOI":"10.1126\/sciimmunol.aam6202"},{"key":"13113_CR70","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1111\/j.1600-6143.2007.01997.x","volume":"7","author":"WH Kitchens","year":"2007","unstructured":"Kitchens, W. H. et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am. J. Transplant. 7, 2675\u20132682 (2007).","journal-title":"Am. J. Transplant."},{"key":"13113_CR71","doi-asserted-by":"crossref","unstructured":"Tible, M. et al. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.\u00a0J. Heart and Lung Transplant.\u00a032, 769-776 (2013).","DOI":"10.1016\/j.healun.2013.05.012"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13113-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:16:38Z","timestamp":1671225398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13113-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13113"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13113-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736989540.793582328","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5350"}}